Received Feb 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
patient received dose 1 on February 8, 2024 and has not received dose 2 yet; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 61-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (patient received 1st dose on February 8, 2024 batch number 542E3). On an unknown date, the patient did not received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: patient received dose 1 on February 8, 2024 and has not received dose 2 yet). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 11-FEB-2025 The reporter reported that a patient had inquired about a Shingrix injection. The patient had received dose 1 on February 8, 2024, and had not received dose 2 yet. The reporter did not consent to follow-up Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination.